Evidence map›Paper›PMID 38105608›Full record

ReviewEpigenetics2024

Cut&tag: a powerful epigenetic tool for chromatin profiling.

Zhijun Fu, Sanjie Jiang, Yiwen Sun, Shanqiao Zheng, Liang Zong, Peipei Li

Abstract readReview
In one paragraph

Review in Epigenetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhijun FuBGI Tech Solutions Co, Ltd. BGI-Shenzhen, Shenzhen, China.
Sanjie JiangBGI Tech Solutions Co, Ltd. BGI-Shenzhen, Shenzhen, China.
Yiwen SunBGI Tech Solutions Co, Ltd. BGI-Shenzhen, Shenzhen, China.
Shanqiao ZhengBGI Tech Solutions Co, Ltd. BGI-Shenzhen, Shenzhen, China.
Liang ZongBGI Tech Solutions Co, Ltd. BGI-Wuhan, Wuhan, China.
Peipei LiBGI Tech Solutions Co, Ltd. BGI-Shenzhen, Shenzhen, China.ORCID 0000-0001-8862-1503

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Analysis of transcription factors and chromatin modifications at the genome-wide level provides insights into gene regulatory processes, such as transcription, cell differentiation and cellular response. Chromatin immunoprecipitation is the most popular and powerful approach for mapping chromatin, and other enzyme-tethering techniques have recently become available for living cells. Among these, Cleavage Under Targets and Tagmentation (CUT&Tag) is a relatively novel chromatin profiling method that has rapidly gained popularity in the field of epigenetics since 2019. It has also been widely adapted to map chromatin modifications and TFs in different species, illustrating the association of these chromatin epitopes with various physiological and pathological processes. Scalable single-cell CUT&Tag can be combined with distinct platforms to distinguish cellular identity, epigenetic features and even spatial chromatin profiling. In addition, CUT&Tag has been developed as a strategy for joint profiling of the epigenome, transcriptome or proteome on the same sample. In this review, we will mainly consolidate the applications of CUT&Tag and its derivatives on different platforms, give a detailed explanation of the pros and cons of this technique as well as the potential development trends and applications in the future.

Indexed as

ChromatinHigh-Throughput Nucleotide SequencingDNA MethylationEpigenesis, GeneticEpigenomicsChromatinchromatin profilingCUT&Tagepigeneticssingle-cell CUT&TagTn5 tagmentation

Identifiers

PMID38105608
PMCPMC10730171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.